You searched for Emmarie Huetteman - Page 12 of 15 - California Healthline

Watch: Big Week For Drug Pricing Debate Featured On C-SPAN

March 1, 2019

KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.

Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers

By Emmarie Huetteman June 28, 2019

A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.

Universal Health Care For New Yorkers? Not Exactly

By Emmarie Huetteman June 27, 2019

Despite what New York Mayor Bill de Blasio claimed during the first night of the presidential debates, universal health care in the Big Apple is still in the seeding stage.

Trump Administration Rule Would Undo Health Care Protections For LGBTQ Patients

By Emmarie Huetteman June 13, 2019

Supporters of the rule say it would strengthen health care professionals’ freedom of conscience, but opponents say it “empowers bad actors to be bad actors.”

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

By Emmarie Huetteman June 12, 2019

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

Investors’ Deep-Pocket Push To Defend Surprise Medical Bills

By Rachel Bluth and Emmarie Huetteman September 11, 2019

As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.

Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High

By Emmarie Huetteman April 26, 2019

It’s as shady as it sounds.

Pharma Cash Rolls Into Congress To Defend An Embattled Industry

By Emmarie Huetteman and Jay Hancock and Elizabeth Lucas August 27, 2019

Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.

Trump Zeroes In On Surprise Medical Bills In White House Chat With Patients, Experts

By Emmarie Huetteman January 23, 2019

Patients and doctors got a chance to share their nightmarish experiences with medical bills with President Donald Trump and other top White House officials.

Drugmakers Funnel Millions In Campaign Donations To Lawmakers

October 24, 2018

Filter Results